Mahsa Emam, OD
Optometrist · Mercer Island, WANPI 1396202016
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 123 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 7 manufacturers reported payments, led by Coopervision Inc. at 29.6% of the total. Reporting peaked in 2021 at $1,479 and has fallen 51.6% since, to $716 in 2025. Among optometrist clinicians in WA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 123 payments — averaging $41.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Coopervision Inc.$2K
- Alcon$1K
- Johnson & Johnson Vision Care, Inc.$1K
- Bausch & Lomb Americas Inc.$690
- Bausch & Lomb, A Division Of Bausch Health US, LLC$460
- Sun Pharmaceutical Industries Inc.$122
- plus $20 from 1 others
What the payments were for
- Food & beverage$5,069100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Coopervision Inc. | 26 | $1,503 |
| Alcon | 26 | $1,213 |
| Johnson & Johnson Vision Care, Inc. | 45 | $1,062 |
| Bausch & Lomb Americas Inc. | 11 | $690 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 13 | $460 |
| Sun Pharmaceutical Industries Inc. | 1 | $122 |
| Biotissue Holdings Inc. | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Acuvue$416
- INFUSE$402
- Precision 1$272
- TOTAL30$249
- MiSight Contact Lens$242
- MyDay Contact Lens$223
- BIOTRUE ONE DAY$125
- ULTRA$125
- Clariti Contact Lens$124
- INFUSE MULTIFOCAL$123
- CEQUA$122
How this compares
$5,069 in reported general payments places this provider in the 95th percentile of 1,267 optometrist providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Azelastine Hcl | 11 | $370 |
Paid to pharmacies, not to this prescriber.
Other optometrist in Mercer Island
- David KadingKirkland$397K
- Peter BergenskeOtis Orchards$355K
- Casey ClaypoolSpokane Valley$323K
- Charles ClaytonBellevue$195K
- Herminder BoparaiBellevue$131K
- Rajiv PatelVancouver$118K
- Alan ChousTacoma$115K
- Roya HabibiSeattle$109K
- Bryan HeitmeyerKent$67K
- Kevin OsborneMoses Lake$47K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.